Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F4F2T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $128,344
Award facts
- Contract value 100% obligated
- $128,344.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $128,344.45 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on January 20, 2026, with an ultimate completion date of January 21, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a task order against AmerisourceBergen's parent company, Cencora, Inc.'s, existing Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 through December 2031.
AmerisourceBergen serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, supplying an extensive portfolio of brand-name and generic medications, specialty drugs, vaccines, and medical devices across multiple therapeutic domains. The company's substantial IDC with DLA enables efficient fulfillment of government pharmaceutical procurement requirements, supporting military treatment facilities and federal medical institutions worldwide. This delivery order for Dupixent, a specialty pharmaceutical treatment, exemplifies the company's role in supplying essential medications to support Department of Defense healthcare programs and operations.
Quick answers
Who was awarded contract SPE2DR26F4F2T?
SPE2DR26F4F2T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F4F2T worth?
The government has obligated $128,344 on SPE2DR26F4F2T.
Is contract SPE2DR26F4F2T an order under another contract?
Yes. SPE2DR26F4F2T is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4F2T competed?
The extent of competition for SPE2DR26F4F2T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award